Top Canonical Pathways | p-value | Overlap | Ratio |
EIF2 Signaling | 9.53E-08 | 13.1% | 29/221 |
Intrinsic Prothrombin Activation Pathway | 1.99E-07 | 34.5% | 10/29 |
LXR/RXR Activation | 2.25E-07 | 16.5% | 20/121 |
Tryptophan Degradation III | 3.58E-07 | 37.5% | 9/24 |
Super-pathway of Cholesterol Biosynthesis | 1.62E-06 | 32.1% | 9/28 |
Top Upstream Regulators | p-value of overlap | # Target genes | |
HNF4A | 4.81E-14 | 161 | |
MYC | 5.70E-11 | 93 | |
PPARA | 1.34E-10 | 50 | |
ESR1 | 5.09E-10 | 150 | |
NFE2L2 | 9.70E-08 | 105 | |
Top Molecular and Cellular Functions | p-value | # Genes | |
Protein Synthesis | 2.61E-03 - 8.55E-11 | 139 | |
Lipid Metabolism | 3.08E-03 - 7.82E-10 | 173 | |
Small Molecule Biochemistry | 3.33E-03 - 7.82E-10 | 212 | |
Amino Acid Metabolism | 3.19E-03 - 4.41E-09 | 47 | |
Vitamin and Mineral Metabolism | 2.18E-03 - 7.36E-09 | 61 | |
Physiological System Development and Function | p-value | # Genes | |
Tissue Morphology | 3.00E-03 - 1.44E-06 | 131 | |
Organismal Development | 3.31E-03 - 1.84E-06 | 246 | |
Connective Tissue Development and Function | 2.92E-03 - 5.93E-06 | 158 | |
Tissue Development | 3.31E-03 - 5.93E-06 | 159 | |
Digestive System Development and Function | 1.85E-03 - 7.57E-06 | 77 | |
Hepatotoxicity | p-value | # Genes | |
Hepatocellular Carcinoma | 6.04E-01 - 9.22E-05 | 64 | |
Liver Hyperplasia/Hyperproliferation | 6.04E-01 - 9.22E-05 | 313 | |
Liver Fibrosis | 4.36E-01 - 2.50E-04 | 23 | |
Liver Proliferation | 4.60E-01 - 2.50E-04 | 24 | |
Liver Necrosis/Cell Death | 4.04E-01 - 1.85E-03 | 20 | |
Top Up-regulated genes | log2 Rf+/Rf- | Top Down-regulated genes | log2 Rf+/Rf- |
FKERa | 3.43 | HMGCS1 | −3.61 |
AHSG | 2.57 | OVCH2 | −2.61 |
SPINK5 | 2.38 | ANKRD22 | −2.58 |
ALB | 2.27 | HMGCL | −2.40 |
SLC13A3 | 2.21 | LGALS1 | −2.34 |
SERPINC1 | 2.17 | RBP7 | −2.09 |
ANGPTL3 | 2.14 | ACAT2 | −1.99 |
PLG | 2.10 | TPPP | −1.92 |
GATM | 2.06 | EIF5B | −1.78 |
NEBL | 2.06 | RPL22L1 | −1.78 |